Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Influenza A (mmu05164)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1810009J
06Rik
KLA  ATP  ATP+KLA
 NM_023707 RIKEN cDNA 1810009J06 gene (1810009J06Rik), mRNA [NM_023707] KLA .94 1.09 1.01 .98 1.05 .99 1.19
ATP .96 .90 .96 1.04 .99 1.07 1.05
KLA/ATP 1.02 .98 1.01 1.09 1.08 1.06 1.01
2210010C
04Rik
KLA  ATP  ATP+KLA
 NM_023333 RIKEN cDNA 2210010C04 gene (2210010C04Rik), mRNA [NM_023333] KLA 1.36 1.41 1.44 1.22 1.24 1.13 1.10
ATP 1.02 .98 1.05 .96 1.01 1.02 1.06
KLA/ATP 1.35 1.18 1.33 1.15 1.02 1.06 1.09
AK030935
KLA  ATP  ATP+KLA
 AK030935 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830463N04 product:unclassifiable, full insert sequence [AK030935] KLA 1.91 1.77 1.68 1.33 1.52 1.15 1.12
ATP 1.32 1.92 1.65 1.60 1.50 1.33 1.16
KLA/ATP 2.19 3.02 2.13 1.95 1.75 1.42 1.31
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Adar
KLA  ATP  ATP+KLA
 NM_001038587 adenosine deaminase, RNA-specific (Adar), transcript variant 1, mRNA [NM_001038587] KLA 5.28 5.13 4.53 4.02 4.14 3.44 2.88
ATP 1.30 1.41 1.07 1.26 1.55 3.27 2.25
KLA/ATP 5.63 6.36 4.32 6.87 6.03 6.89 6.51
Adar
KLA  ATP  ATP+KLA
 NM_019655 adenosine deaminase, RNA-specific (Adar), transcript variant 1, mRNA [NM_019655] KLA 4.04 4.23 4.16 3.97 3.67 3.70 3.37
ATP 1.05 1.05 .80 .67 .74 3.23 3.93
KLA/ATP 4.62 4.13 3.21 3.21 2.14 5.80 8.51
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
Bat1a
KLA  ATP  ATP+KLA
 NM_019693 HLA-B-associated transcript 1A (Bat1a), mRNA [NM_019693] KLA 1.15 1.21 1.36 1.17 1.39 1.22 1.07
ATP 1.15 1.27 .91 1.33 1.30 1.23 .92
KLA/ATP 1.41 1.41 .90 1.53 1.07 1.15 1.09
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Ccl12
KLA  ATP  ATP+KLA
 NM_011331 chemokine (C-C motif) ligand 12 (Ccl12), mRNA [NM_011331] KLA 40.77 33.71 46.23 51.22 57.13 57.92 16.26
ATP 1.41 1.14 1.54 1.79 1.41 1.89 9.34
KLA/ATP 39.52 43.18 61.96 69.72 62.95 38.70 29.25
Ccl2
KLA  ATP  ATP+KLA
 NM_011333 chemokine (C-C motif) ligand 2 (Ccl2), mRNA [NM_011333] KLA 10.26 9.30 8.35 10.02 8.92 14.08 11.59
ATP 1.62 1.68 2.20 4.16 3.92 4.84 17.45
KLA/ATP 10.09 10.31 10.95 12.32 8.00 10.04 21.29
Ccl5
KLA  ATP  ATP+KLA
 M77747 rantes mRNA, complete cds. [M77747] KLA 63.18 60.41 56.25 63.63 58.00 66.51 67.20
ATP .91 1.08 1.25 1.90 4.34 16.10 26.07
KLA/ATP 55.92 63.34 72.91 65.68 70.81 71.97 81.34
Ccl5
KLA  ATP  ATP+KLA
 NM_013653 chemokine (C-C motif) ligand 5 (Ccl5), mRNA [NM_013653] KLA 40.31 35.22 27.92 38.59 29.29 37.98 28.83
ATP .86 .92 1.43 1.66 3.86 15.09 16.66
KLA/ATP 32.14 31.72 47.19 35.89 42.00 46.15 43.89
Ciita
KLA  ATP  ATP+KLA
 NM_007575 class II transactivator (Ciita), mRNA [NM_007575] KLA 2.13 2.12 2.35 2.22 1.91 1.44 1.12
ATP 1.04 1.04 1.17 1.17 1.61 1.15 1.21
KLA/ATP 2.23 2.44 1.88 1.76 1.64 1.14 1.52
Cpsf4
KLA  ATP  ATP+KLA
 NM_178576 cleavage and polyadenylation specific factor 4 (Cpsf4), mRNA [NM_178576] KLA .86 .83 .88 .87 .90 1.22 1.13
ATP .94 .89 .69 .65 .91 1.22 .97
KLA/ATP .82 .78 .72 .66 .84 1.28 1.18
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Cxcl10
KLA  ATP  ATP+KLA
 NM_021274 chemokine (C-X-C motif) ligand 10 (Cxcl10), mRNA [NM_021274] KLA 986.69 854.98 711.49 799.39 542.62 686.82 183.27
ATP .98 1.71 9.85 73.04 100.42 184.63 8.33
KLA/ATP 842.13 793.12 ###.## ###.## ###.## 715.22 496.10
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
D430028G
21Rik
KLA  ATP  ATP+KLA
 NM_144888 RIKEN cDNA D430028G21 gene (D430028G21Rik), mRNA [NM_144888] KLA .56 .54 .61 .60 .74 1.03 1.06
ATP 1.07 .99 .69 .66 .48 .96 1.38
KLA/ATP .61 .60 .38 .41 .42 1.00 1.40
Ddx58
KLA  ATP  ATP+KLA
 NM_172689 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58), mRNA [NM_172689] KLA 8.80 9.12 9.70 9.96 9.92 7.85 5.67
ATP 1.06 .89 .97 .89 .80 3.03 3.67
KLA/ATP 9.18 9.23 10.31 9.25 7.29 6.93 8.99
Dnajb1
KLA  ATP  ATP+KLA
 NM_018808 DnaJ (Hsp40) homolog, subfamily B, member 1 (Dnajb1), mRNA [NM_018808] KLA .82 .80 1.05 1.23 1.58 1.83 1.25
ATP 1.06 1.05 3.81 13.63 10.70 3.38 1.07
KLA/ATP .83 .91 3.21 10.03 12.53 5.11 1.86
Dnajc3a
KLA  ATP  ATP+KLA
 NM_008929 DnaJ (Hsp40) homolog, subfamily C, member 3A (Dnajc3a), mRNA [NM_008929] KLA .94 .98 .88 .87 .76 .75 .96
ATP 1.00 1.01 1.13 1.09 1.05 1.15 1.58
KLA/ATP .95 .97 1.06 .99 .87 .87 .93
Eif2ak1
KLA  ATP  ATP+KLA
 AK032508 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574E03 product:EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 (EC 2.7.1.-) (HEME-REGULATED EUKARYOTIC INITIATION FACTOR EIF-2-ALPHA KINASE) (HEME-R KLA .65 .66 .65 .67 .67 .85 1.06
ATP 1.07 1.13 1.10 1.03 .70 .63 .72
KLA/ATP .68 .73 .70 .67 .65 .66 .47
Eif2ak1
KLA  ATP  ATP+KLA
 NM_013557 eukaryotic translation initiation factor 2 alpha kinase 1 (Eif2ak1), mRNA [NM_013557] KLA 1.16 1.19 1.32 1.21 1.58 1.51 1.59
ATP 1.19 1.27 .93 1.28 1.02 1.53 1.60
KLA/ATP 1.36 1.50 1.16 1.38 1.12 1.79 2.42
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Eif2ak3
KLA  ATP  ATP+KLA
 AK041698 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630030N06 product:unclassifiable, full insert sequence. [AK041698] KLA .79 .77 .83 .80 .93 .87 .85
ATP .82 .82 .82 .92 .88 .85 .91
KLA/ATP .77 .76 .78 .80 .84 .86 .81
Eif2ak3
KLA  ATP  ATP+KLA
 NM_010121 eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), mRNA [NM_010121] KLA .28 .28 .27 .29 .38 .36 .47
ATP 1.17 1.04 .62 .48 .54 .48 .67
KLA/ATP .29 .30 .26 .26 .34 .37 .32
Eif2ak4
KLA  ATP  ATP+KLA
 AF193344 GCN2gamma mRNA, complete cds [AF193344] KLA .78 .78 .66 .72 .79 .83 1.05
ATP .97 1.06 .97 .97 .98 .86 .94
KLA/ATP .81 .73 .62 .84 .81 .88 .90
Eif2ak4
KLA  ATP  ATP+KLA
 NM_013719 eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4), mRNA [NM_013719] KLA .60 .55 .49 .54 .59 .67 .91
ATP 1.11 1.18 1.00 .94 1.33 .90 .98
KLA/ATP .59 .54 .56 .58 .90 .86 .86
Eif2s1
KLA  ATP  ATP+KLA
 NM_026114 eukaryotic translation initiation factor 2, subunit 1 alpha (Eif2s1), mRNA [NM_026114] KLA 1.50 1.49 1.52 1.49 1.24 1.12 1.25
ATP 1.00 .98 1.16 1.05 1.03 1.10 .99
KLA/ATP 1.50 1.54 1.73 1.39 1.24 .87 .66
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Fas
KLA  ATP  ATP+KLA
 AK086933 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030012O08 product:tumor necrosis factor receptor superfamily, member 6, full insert sequence. [AK086933] KLA 6.31 6.56 6.33 6.70 4.93 3.74 2.48
ATP .95 1.04 1.33 1.55 1.85 6.00 2.77
KLA/ATP 5.67 7.16 7.71 7.73 6.02 5.79 7.85
Fas
KLA  ATP  ATP+KLA
 NM_007987 Fas (TNF receptor superfamily member 6) (Fas), mRNA [NM_007987] KLA 17.08 17.45 19.08 17.38 13.33 6.78 4.46
ATP .98 .96 1.64 3.05 5.58 12.91 1.89
KLA/ATP 16.57 17.25 26.06 23.57 22.03 16.74 13.29
Fasl
KLA  ATP  ATP+KLA
 NM_010177 Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] KLA 1.03 1.01 1.03 1.02 1.01 1.01 1.00
ATP 1.00 .99 1.04 1.21 1.18 1.20 1.01
KLA/ATP 1.00 1.02 1.07 1.16 1.18 1.23 1.00
Fdps
KLA  ATP  ATP+KLA
 AK077979 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030492I17 product:farnesyl diphosphate synthetase, full insert sequence. [AK077979] KLA .76 .79 .79 .69 .65 .37 .49
ATP .63 .70 .85 .30 .46 .89 .86
KLA/ATP .54 .52 .63 .39 .42 .40 .31
Fdps
KLA  ATP  ATP+KLA
 NM_134469 farnesyl diphosphate synthetase (Fdps), mRNA [NM_134469] KLA .87 .93 .89 .97 .76 .43 .48
ATP 1.12 1.10 1.05 1.23 1.05 .60 .88
KLA/ATP .93 .99 1.00 1.02 .70 .45 .33
Furin
KLA  ATP  ATP+KLA
 AK079271 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530072A02 product:unclassifiable, full insert sequence. [AK079271] KLA .94 .95 .97 1.07 .88 .88 1.01
ATP .98 .93 1.00 1.26 .87 .97 .97
KLA/ATP .96 .98 .91 1.09 .96 .90 .96
Furin
KLA  ATP  ATP+KLA
 NM_011046 furin (paired basic amino acid cleaving enzyme) (Furin), mRNA [NM_011046] KLA 2.02 1.80 1.90 2.02 1.86 1.43 .85
ATP .94 .95 1.08 1.45 3.67 5.84 1.62
KLA/ATP 1.70 1.74 2.04 2.96 5.36 7.54 2.47
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
Hnrpul1
KLA  ATP  ATP+KLA
 AK155604 B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730016K03 product:heterogeneous nuclear ribonucleoprotein U-like 1, full insert sequence [AK155604] KLA .91 .91 .80 .93 .83 1.07 .85
ATP .88 .95 1.15 1.12 .83 .64 .69
KLA/ATP .86 .83 .93 1.01 .79 .72 .80
Hnrpul1
KLA  ATP  ATP+KLA
 NM_144922 heterogeneous nuclear ribonucleoprotein U-like 1 (Hnrpul1), transcript variant 1, mRNA [NM_144922] KLA 1.09 1.10 1.09 1.06 1.00 1.17 1.04
ATP 1.01 1.11 1.06 1.15 .87 .91 .94
KLA/ATP 1.05 1.13 1.07 1.07 .85 .91 .96
Hnrpul1
KLA  ATP  ATP+KLA
 NM_178089 heterogeneous nuclear ribonucleoprotein U-like 1 (Hnrpul1), transcript variant 2, mRNA [NM_178089] KLA 1.29 1.27 1.20 1.30 1.15 1.21 1.02
ATP .95 .95 1.22 1.09 .93 .89 1.14
KLA/ATP 1.25 1.22 1.44 1.28 1.11 .86 .99
Hrb
KLA  ATP  ATP+KLA
 AK156102 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008A13 product:unclassifiable, full insert sequence [AK156102] KLA .99 .91 .90 .91 1.08 .83 .63
ATP .98 .98 .89 .97 1.22 .61 .33
KLA/ATP .98 .91 .80 .84 .95 .73 .29
Hrb
KLA  ATP  ATP+KLA
 NM_010472 HIV-1 Rev binding protein (Hrb), mRNA [NM_010472] KLA 1.54 1.52 1.53 1.54 1.57 1.57 1.30
ATP .96 1.02 1.08 .99 1.43 1.34 1.15
KLA/ATP 1.46 1.45 1.35 1.27 1.12 1.25 1.42
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Ifih1
KLA  ATP  ATP+KLA
 NM_027835 interferon induced with helicase C domain 1 (Ifih1), mRNA [NM_027835] KLA 37.11 33.14 35.90 33.98 21.58 12.10 6.89
ATP 1.03 .97 .74 .73 1.20 4.28 2.92
KLA/ATP 33.28 36.92 27.96 24.80 12.35 8.39 10.11
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbke
KLA  ATP  ATP+KLA
 NM_019777 inhibitor of kappaB kinase epsilon (Ikbke), mRNA [NM_019777] KLA 6.03 5.91 6.38 6.89 7.05 6.70 4.74
ATP 1.02 1.11 .82 1.16 1.18 2.08 1.90
KLA/ATP 6.04 6.71 5.69 5.30 2.49 2.33 5.43
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il1a
KLA  ATP  ATP+KLA
 NM_010554 interleukin 1 alpha (Il1a), mRNA [NM_010554] KLA 32.45 35.22 31.30 20.95 28.57 18.36 19.02
ATP 1.04 1.02 2.21 5.46 11.06 32.07 3.40
KLA/ATP 32.02 41.20 35.12 46.91 28.76 42.72 57.80
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il33
KLA  ATP  ATP+KLA
 NM_133775 interleukin 33 (Il33), mRNA [NM_133775] KLA 2.34 2.27 2.62 2.36 1.87 1.34 1.07
ATP 1.13 .97 1.07 1.09 2.09 9.35 1.19
KLA/ATP 2.38 2.26 2.15 2.10 2.48 7.29 3.89
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Irak4
KLA  ATP  ATP+KLA
 NM_029926 interleukin-1 receptor-associated kinase 4 (Irak4), mRNA [NM_029926] KLA .82 .86 .78 .82 .95 1.21 1.22
ATP 1.02 1.18 .95 1.10 .79 .85 .82
KLA/ATP .86 .89 .77 .90 .78 .96 .88
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Irf7
KLA  ATP  ATP+KLA
 NM_016850 interferon regulatory factor 7 (Irf7), mRNA [NM_016850] KLA 4.90 4.72 5.85 5.82 7.67 10.64 15.44
ATP 1.14 1.10 .86 1.18 .96 2.46 12.17
KLA/ATP 5.41 5.22 4.15 6.29 5.31 9.74 29.08
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Ivns1abp
KLA  ATP  ATP+KLA
 NM_001039511 influenza virus NS1A binding protein (Ivns1abp), transcript variant 1, mRNA [NM_001039511] KLA .83 .84 .78 .77 .71 .77 .71
ATP 1.01 1.04 .94 .93 .90 1.05 .92
KLA/ATP .77 .77 .77 .81 .79 .76 .66
Ivns1abp
KLA  ATP  ATP+KLA
 NM_054102 influenza virus NS1A binding protein (Ivns1abp), transcript variant 2, mRNA [NM_054102] KLA .48 .50 .45 .34 .19 .18 .31
ATP .91 .86 1.00 .92 .98 .45 .34
KLA/ATP .48 .46 .56 .48 .49 .26 .14
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Kpna1
KLA  ATP  ATP+KLA
 NM_008465 karyopherin (importin) alpha 1 (Kpna1), mRNA [NM_008465] KLA 1.13 1.24 1.13 1.07 .97 .91 1.12
ATP 1.10 1.22 1.15 1.17 1.33 2.22 1.28
KLA/ATP 1.25 1.19 .97 1.10 1.21 1.60 1.29
Kpna2
KLA  ATP  ATP+KLA
 NM_010655 karyopherin (importin) alpha 2 (Kpna2), mRNA [NM_010655] KLA .54 .51 .44 .42 .51 .62 .52
ATP 1.03 1.08 1.04 .85 1.08 1.23 .50
KLA/ATP .58 .49 .45 .44 .56 .78 .31
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Map2k3
KLA  ATP  ATP+KLA
 NM_008928 mitogen-activated protein kinase kinase 3 (Map2k3), mRNA [NM_008928] KLA .88 .88 .73 .65 .99 1.34 .92
ATP 1.04 1.09 .89 1.62 1.93 1.75 1.17
KLA/ATP 1.00 .92 .66 1.21 1.80 2.24 2.10
Map2k4
KLA  ATP  ATP+KLA
 NM_009157 mitogen-activated protein kinase kinase 4 (Map2k4), mRNA [NM_009157] KLA 3.67 3.75 4.23 3.90 3.30 1.87 1.12
ATP 1.05 1.11 1.04 .93 1.16 2.62 1.02
KLA/ATP 3.70 4.13 3.27 4.13 2.98 3.03 1.82
Map2k6
KLA  ATP  ATP+KLA
 NM_011943 mitogen-activated protein kinase kinase 6 (Map2k6), mRNA [NM_011943] KLA .68 .67 .64 .67 .62 .59 .61
ATP 1.02 1.12 1.04 1.10 .79 .61 .61
KLA/ATP .73 .69 .71 .74 .66 .62 .98
Map2k7
KLA  ATP  ATP+KLA
 BC070467 mitogen activated protein kinase kinase 7, mRNA (cDNA clone MGC:96654 IMAGE:30615302), complete cds [BC070467] KLA .77 .79 .88 .77 .97 .96 1.27
ATP 1.11 1.26 .93 1.19 1.13 1.45 1.16
KLA/ATP .89 .88 .59 .89 .86 1.32 1.28
Map2k7
KLA  ATP  ATP+KLA
 NM_001042557 mitogen-activated protein kinase kinase 7 (Map2k7), transcript variant 1, mRNA [NM_001042557] KLA .96 .95 1.02 .96 .95 1.09 1.19
ATP 1.02 1.07 .88 .97 .93 1.10 1.17
KLA/ATP 1.01 .99 .80 .87 .76 1.21 1.16
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mm.12616
KLA  ATP  ATP+KLA
 31542562 Unknown KLA 1.02 1.06 .92 .95 .78 .75 .71
ATP 1.02 1.12 1.35 1.01 .89 .77 .89
KLA/ATP 1.13 1.09 1.10 1.00 .70 .57 .44
Mm.14301
KLA  ATP  ATP+KLA
 21630282 Unknown KLA 3.97 3.92 3.89 4.78 4.16 4.22 3.83
ATP .97 .93 1.27 1.16 1.01 2.62 4.12
KLA/ATP 3.93 4.01 4.75 4.44 4.41 3.51 5.56
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.33624
4
KLA  ATP  ATP+KLA
 158508452 Unknown KLA 1.01 1.08 .97 .96 1.00 .96 .92
ATP .95 .99 .98 .99 .97 1.01 1.03
KLA/ATP .95 .96 1.08 .97 .97 .96 .97
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.41292
2
KLA  ATP  ATP+KLA
 145966829 Unknown KLA 3.65 3.76 3.75 3.79 3.42 1.75 1.10
ATP 1.11 1.17 1.04 .90 1.37 2.90 1.00
KLA/ATP 3.31 3.97 3.38 3.84 3.04 3.31 2.09
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mx2
KLA  ATP  ATP+KLA
 NM_013606 myxovirus (influenza virus) resistance 2 (Mx2), mRNA [NM_013606] KLA 80.14 64.79 53.92 46.34 41.28 43.08 14.59
ATP 1.31 1.14 1.23 1.56 2.44 18.08 7.52
KLA/ATP 80.41 69.29 77.21 58.46 40.11 46.89 57.79
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Nlrp3
KLA  ATP  ATP+KLA
 NM_145827 NLR family, pyrin domain containing 3 (Nlrp3), mRNA [NM_145827] KLA 4.67 4.59 4.29 3.00 4.04 2.15 1.70
ATP 1.00 1.06 1.26 4.90 5.57 4.69 .69
KLA/ATP 4.03 4.02 2.51 5.32 2.64 4.12 2.61
Nlrx1
KLA  ATP  ATP+KLA
 NM_178420 NLR family member X1 (Nlrx1), mRNA [NM_178420] KLA .68 .69 .68 .71 .80 1.07 1.29
ATP 1.03 1.08 .92 .92 .50 .63 1.02
KLA/ATP .70 .69 .66 .69 .54 .68 1.19
Nup98
KLA  ATP  ATP+KLA
 BC078630 nucleoporin 98, mRNA (cDNA clone IMAGE:30465124), partial cds [BC078630] KLA 3.04 3.20 3.38 3.15 2.46 1.74 1.36
ATP 1.03 1.09 1.24 1.79 2.24 1.79 .98
KLA/ATP 2.92 3.38 3.91 3.93 3.27 2.69 1.67
Nup98
KLA  ATP  ATP+KLA
 NM_022979 nucleoporin 98 (Nup98), mRNA [NM_022979] KLA 2.51 2.59 2.48 1.94 1.54 1.29 1.13
ATP 1.01 1.04 1.17 1.28 1.25 1.39 1.34
KLA/ATP 2.63 2.53 2.27 2.30 1.47 1.48 1.24
Nxf1
KLA  ATP  ATP+KLA
 NM_016813 nuclear RNA export factor 1 homolog (S. cerevisiae) (Nxf1), mRNA [NM_016813] KLA 2.56 2.72 2.83 1.97 1.27 1.06 1.10
ATP 1.00 1.13 1.32 2.04 1.64 1.48 1.15
KLA/ATP 2.81 2.91 2.72 4.35 2.42 1.54 1.32
Nxf2
KLA  ATP  ATP+KLA
 NM_031259 nuclear RNA export factor 2 (Nxf2), mRNA [NM_031259] KLA .95 .97 .90 1.00 .91 .90 1.04
ATP 1.04 1.07 .99 1.02 .87 .89 .95
KLA/ATP .94 .89 .88 .95 .85 .90 .85
Nxf3
KLA  ATP  ATP+KLA
 NM_001024141 nuclear RNA export factor 3 (Nxf3), mRNA [NM_001024141] KLA .95 1.03 1.02 1.04 .95 .96 .98
ATP 1.09 .96 1.01 1.01 .95 .96 1.05
KLA/ATP 1.05 1.07 1.08 1.07 .95 1.00 .94
Nxf7
KLA  ATP  ATP+KLA
 NM_130888 nuclear RNA export factor 7 (Nxf7), mRNA [NM_130888] KLA 1.06 .97 .99 1.02 .98 .96 .94
ATP 1.01 1.06 1.04 .95 .99 1.01 .99
KLA/ATP .95 1.01 .97 .95 .94 .93 1.10
Nxt1
KLA  ATP  ATP+KLA
 NM_019761 NTF2-related export protein 1 (Nxt1), transcript variant 2, mRNA [NM_019761] KLA .46 .46 .49 .50 .63 .91 .90
ATP .93 .95 1.08 .96 1.61 3.34 1.02
KLA/ATP .44 .47 .59 .54 1.18 2.80 1.16
Nxt2
KLA  ATP  ATP+KLA
 NM_172782 nuclear transport factor 2-like export factor 2 (Nxt2), mRNA [NM_172782] KLA 1.07 1.12 1.13 1.01 .98 .94 1.01
ATP .98 1.26 1.17 1.44 1.13 .99 .61
KLA/ATP 1.08 1.22 .98 1.32 .97 1.07 .80
Oas1a
KLA  ATP  ATP+KLA
 NM_145211 2-5 oligoadenylate synthetase 1A (Oas1a), mRNA [NM_145211] KLA 2.26 2.33 2.50 2.33 3.11 3.74 3.99
ATP .99 1.04 .93 1.03 .91 1.63 3.44
KLA/ATP 2.49 2.39 1.91 2.51 2.28 3.09 6.06
Oas1b
KLA  ATP  ATP+KLA
 NM_001083925 2-5 oligoadenylate synthetase 1B (Oas1b), mRNA [NM_001083925] KLA 3.54 3.55 4.22 4.22 4.93 5.27 4.14
ATP 1.13 1.08 1.05 1.19 1.06 2.13 2.67
KLA/ATP 3.53 3.76 3.24 5.16 4.36 4.05 7.31
Oas1g
KLA  ATP  ATP+KLA
 NM_011852 2-5 oligoadenylate synthetase 1G (Oas1g), mRNA [NM_011852] KLA 2.58 2.75 2.53 2.84 2.60 2.74 2.56
ATP .97 1.03 1.20 1.17 1.07 1.82 2.47
KLA/ATP 2.58 2.80 2.68 2.60 2.21 2.27 3.01
Oas2
KLA  ATP  ATP+KLA
 NM_145227 2-5 oligoadenylate synthetase 2 (Oas2), mRNA [NM_145227] KLA 3.37 3.26 3.43 2.80 3.59 3.57 2.15
ATP 1.10 1.20 1.04 .86 .94 3.23 3.09
KLA/ATP 3.85 3.75 3.15 3.70 4.00 5.52 7.31
Oas3
KLA  ATP  ATP+KLA
 NM_145226 2-5 oligoadenylate synthetase 3 (Oas3), mRNA [NM_145226] KLA 2.32 2.35 2.67 2.63 3.37 3.80 4.07
ATP 1.06 1.10 1.02 1.26 1.02 1.47 3.58
KLA/ATP 2.62 2.57 2.39 3.18 2.67 3.05 6.15
Pabpn1
KLA  ATP  ATP+KLA
 AK137240 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530063N22 product:poly(A) binding protein, nuclear 1, full insert sequence. [AK137240] KLA 1.06 1.14 .99 1.19 1.06 1.19 1.07
ATP .95 1.12 1.07 1.45 1.20 1.12 .82
KLA/ATP 1.04 1.45 1.28 1.36 1.31 .88 .95
Pabpn1
KLA  ATP  ATP+KLA
 AK157143 activated spleen cDNA, RIKEN full-length enriched library, clone:F830204I09 product:poly(A) binding protein, nuclear 1, full insert sequence [AK157143] KLA .57 .53 .57 .69 .91 .72 .98
ATP .75 .61 .29 .46 1.31 .90 .76
KLA/ATP .44 .39 .29 .50 1.02 .69 .86
Pabpn1
KLA  ATP  ATP+KLA
 NM_019402 poly(A) binding protein, nuclear 1 (Pabpn1), mRNA [NM_019402] KLA .82 .86 .71 .73 .93 .89 1.24
ATP 1.17 1.33 .95 1.41 1.03 .82 1.35
KLA/ATP .88 1.01 .68 1.03 .78 .49 1.21
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Plg
KLA  ATP  ATP+KLA
 NM_008877 plasminogen (Plg), mRNA [NM_008877] KLA 1.02 1.05 1.06 1.02 1.01 1.09 1.07
ATP .99 .96 1.07 1.08 1.02 .95 1.09
KLA/ATP 1.09 .98 .98 1.09 1.21 1.08 1.04
Pml
KLA  ATP  ATP+KLA
 NM_008884 promyelocytic leukemia (Pml), transcript variant 1, mRNA [NM_008884] KLA 5.73 6.01 7.28 6.76 5.85 5.36 2.28
ATP 1.07 1.10 .92 .89 .97 3.78 2.67
KLA/ATP 6.48 6.51 6.81 8.78 6.61 7.57 6.55
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prss2
KLA  ATP  ATP+KLA
 NM_009430 protease, serine, 2 (Prss2), mRNA [NM_009430] KLA .94 .99 .95 1.03 .89 1.08 1.06
ATP 1.04 .95 1.00 1.03 .96 .97 1.00
KLA/ATP 1.05 .96 1.01 1.05 1.00 1.11 1.11
Pycard
KLA  ATP  ATP+KLA
 NM_023258 PYD and CARD domain containing (Pycard), mRNA [NM_023258] KLA 1.48 1.44 1.62 1.81 1.80 1.69 .94
ATP .89 .88 1.00 .84 .52 .30 .62
KLA/ATP 1.32 1.34 1.65 1.38 1.14 .50 .41
Rae1
KLA  ATP  ATP+KLA
 BC060072 RAE1 RNA export 1 homolog (S. pombe), mRNA (cDNA clone MGC:73449 IMAGE:5718934), complete cds [BC060072] KLA 1.00 .98 1.00 .91 .94 .92 .94
ATP 1.21 1.33 .97 .87 1.07 .95 .95
KLA/ATP .99 1.00 .95 .88 1.00 .92 .97
Rae1
KLA  ATP  ATP+KLA
 NM_175112 RAE1 RNA export 1 homolog (S. pombe) (Rae1), mRNA [NM_175112] KLA 1.16 1.12 1.00 1.00 .96 .99 1.01
ATP .89 .80 .64 .62 .90 .98 .99
KLA/ATP 1.06 .95 .77 .69 .77 .90 .80
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rnasel
KLA  ATP  ATP+KLA
 NM_011882 ribonuclease L (2, 5-oligoisoadenylate synthetase-dependent) (Rnasel), mRNA [NM_011882] KLA .25 .24 .26 .35 .50 .47 .31
ATP .98 .91 .60 .40 .36 1.12 .53
KLA/ATP .24 .25 .23 .22 .32 1.16 .52
Rsad2
KLA  ATP  ATP+KLA
 NM_021384 radical S-adenosyl methionine domain containing 2 (Rsad2), mRNA [NM_021384] KLA 73.33 65.07 62.26 68.36 51.21 63.38 34.64
ATP 1.15 1.16 1.46 4.89 8.61 45.18 22.78
KLA/ATP 70.94 74.37 86.13 70.34 80.63 88.57 80.01
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Tbk1
KLA  ATP  ATP+KLA
 NM_019786 TANK-binding kinase 1 (Tbk1), mRNA [NM_019786] KLA 2.55 2.76 3.22 2.67 2.56 2.29 1.96
ATP 1.13 1.30 1.12 1.07 1.29 1.41 1.40
KLA/ATP 2.84 3.17 2.58 2.43 1.70 2.15 2.37
Ticam1
KLA  ATP  ATP+KLA
 NM_174989 toll-like receptor adaptor molecule 1 (Ticam1), mRNA [NM_174989] KLA 1.45 1.63 2.02 2.36 3.12 2.34 2.21
ATP 1.16 1.19 .90 2.58 4.78 2.04 1.80
KLA/ATP 1.79 1.71 1.07 2.89 5.60 3.26 3.50
Tlr3
KLA  ATP  ATP+KLA
 NM_126166 toll-like receptor 3 (Tlr3), mRNA [NM_126166] KLA 8.54 10.04 12.64 11.83 10.51 7.08 3.09
ATP 1.09 1.16 1.16 1.16 .77 1.77 2.23
KLA/ATP 10.00 11.77 10.12 12.97 10.43 8.74 7.11
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tlr7
KLA  ATP  ATP+KLA
 NM_133211 toll-like receptor 7 (Tlr7), mRNA [NM_133211] KLA 2.03 2.09 2.28 2.43 2.56 2.48 1.32
ATP 1.01 1.06 1.05 .80 .80 .89 1.37
KLA/ATP 2.04 2.28 2.28 2.40 2.28 1.77 1.06
Tmprss13
KLA  ATP  ATP+KLA
 NM_001013373 transmembrane protease, serine 13 (Tmprss13), mRNA [NM_001013373] KLA 1.00 1.06 .93 .91 .97 .99 .98
ATP 1.02 1.02 1.00 .93 .94 .99 1.10
KLA/ATP .99 1.01 .97 .93 1.00 .96 1.04
Tmprss2
KLA  ATP  ATP+KLA
 NM_015775 transmembrane protease, serine 2 (Tmprss2), mRNA [NM_015775] KLA 1.03 .99 1.01 1.03 1.01 1.04 1.01
ATP 1.03 1.01 .99 1.02 1.00 1.00 .99
KLA/ATP 1.02 1.01 1.07 1.02 1.02 1.00 .99
Tmprss4
KLA  ATP  ATP+KLA
 NM_145403 transmembrane protease, serine 4 (Tmprss4), mRNA [NM_145403] KLA 1.17 1.12 1.09 1.08 1.32 1.71 2.85
ATP 1.02 1.01 1.00 1.06 1.01 1.04 1.07
KLA/ATP 1.17 1.03 1.09 1.06 1.09 1.14 1.51
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf10
b
KLA  ATP  ATP+KLA
 NM_020275 tumor necrosis factor receptor superfamily, member 10b (Tnfrsf10b), mRNA [NM_020275] KLA 1.29 1.24 1.23 1.14 .96 .88 .87
ATP .99 1.04 1.06 1.14 .95 1.10 1.15
KLA/ATP 1.26 1.26 1.21 1.23 1.03 .93 .93
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tnfsf10
KLA  ATP  ATP+KLA
 NM_009425 tumor necrosis factor (ligand) superfamily, member 10 (Tnfsf10), mRNA [NM_009425] KLA 31.48 31.73 32.62 36.94 28.34 23.40 4.96
ATP 1.06 .93 1.28 1.24 1.07 2.74 3.33
KLA/ATP 28.07 30.23 43.53 33.98 27.97 18.71 17.43
Trim25
KLA  ATP  ATP+KLA
 NM_009546 tripartite motif-containing 25 (Trim25), mRNA [NM_009546] KLA 3.93 4.08 4.13 3.67 3.19 3.12 3.13
ATP 1.02 1.00 .92 1.22 2.80 3.73 3.72
KLA/ATP 4.17 4.41 4.23 4.23 5.38 5.22 7.68
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09
Vdac1
KLA  ATP  ATP+KLA
 NM_011694 voltage-dependent anion channel 1 (Vdac1), mRNA [NM_011694] KLA .85 .86 .95 .80 .69 .62 .76
ATP .93 1.01 1.32 1.01 .96 .82 .57
KLA/ATP .81 .85 1.05 .78 .78 .78 .48
Xpo1
KLA  ATP  ATP+KLA
 NM_134014 exportin 1, CRM1 homolog (yeast) (Xpo1), transcript variant 1, mRNA [NM_134014] KLA .85 .84 .92 .94 1.07 1.07 .94
ATP 1.00 .97 .86 .74 .61 .56 .77
KLA/ATP .87 .81 .71 .66 .70 .74 .77